News about " Imovax Rabies"

Sanofi Receives EC Approval for VaxRabeo Rabies Vaccine Across All Age Groups

Sanofi Receives EC Approval for VaxRabeo Rabies Vaccine Across All Age Groups

Sanofi receives European Commission approval for VaxRabeo, a rabies vaccine for all age groups, offering pre- and post-exposure protection, comparable immune responses, improved thermostability and a five-year shelf life.

Imovax Rabies | 20/11/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members